Stefano Bellentani
National Operating Committee on Standards for Athletic Equipment
EpidemiologyInternal medicineEndocrinologyChemistryImmunologySteatosisNonalcoholic fatty liver diseaseLiver diseaseCirrhosisInsulin resistanceFatty liverChronic liver diseaseDiseaseSteatohepatitisMetabolic syndromePopulationIncidence (epidemiology)ObesityMedicineBiologyGastroenterology
159Publications
53H-index
11.2kCitations
Publications 152
Newest
#2Fabio ContiH-Index: 16
Last. Giorgio BedogniH-Index: 61
view all 16 authors...
We externally validated the fatty liver index (FLI), the lipid accumulation product (LAP), the hepatic steatosis index (HSI), and the Zhejiang University index (ZJU) for the diagnosis of fatty liver (FL) and non-alcoholic fatty liver disease (NAFLD) in the general population. The validation was performed on 2159 citizens of the town of Bagnacavallo (Ravenna, Italy). Calibration was evaluated by calculating the calibration slope and intercept and by inspecting calibration plots; discrimination wa...
2 CitationsSource
#2Fabio ContiH-Index: 16
Last. Alessandro Cucchetti (UNIBO: University of Bologna)H-Index: 64
view all 16 authors...
Objective: We externally validated the fatty liver index (FLI), the lipid accumulation product (LAP), the hepatic steatosis index (HSI), and the Zhejiang University index (ZJU) for the diagnosis of fatty liver (FL) and non-alcoholic fatty liver disease (NAFLD) in the general population. Subjects and Methods: The validation was performed on 2159 citizens of the town of Bagnacavallo (Ravenna, Italy). Calibration was evaluated by calculating the calibration slope and intercept and by inspecting cal...
Source
#1Francesco Giuseppe Foschi (AUSL: Academy for Urban School Leadership)H-Index: 26
#2Marco Domenicali (UNIBO: University of Bologna)H-Index: 35
Last. Giorgio BedogniH-Index: 61
view all 17 authors...
Abstract Introduction and objectives Surrogate biomarkers of liver fibrosis developed in tertiary care are increasingly used in general populations. We evaluated the association between liver stiffness (LS) and five continuous (AST/ALT, APRI, Forns Index, FIB-4, GGT) and two discrete biomarkers (BARD, BAAT) in a general population. Patients and methods 636 (29%) of the 2159 citizens of the Bagnacavallo Study had LS measured by transient elastography. Using linear regression with univariate multi...
10 CitationsSource
#1Natalia RossoH-Index: 17
#2Stefano BellentaniH-Index: 53
Nonalcoholic Liver Disease (NAFLD) is considered a wide spectrum progressive disease and has emerged as a major cause of chronic liver disease worldwide. It has a global prevalence of 24%, an increasing incidence in both adults and children, in parallel with the pandemic burden of obesity, Type 2 Diabetes Mellitus (T2DM) and Metabolic Syndrome (MS). The pathogenic drivers are still unknown and are not likely to be identical among all patients. The natural history of NAFLD is not linear: it progr...
2 CitationsSource
#1Nicolas Goossens (Geneva College)H-Index: 22
#2Stefano BellentaniH-Index: 53
Last. Chris EstesH-Index: 20
view all 12 authors...
As a result of epidemic levels of obesity and diabetes mellitus, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) will contribute to increases in the liver-related disease burden in Switzerland.
4 CitationsSource
#1Franca MarangoniH-Index: 23
#2Luisa Pellegrino (University of Milan)H-Index: 21
Last. Andrea PoliH-Index: 27
view all 34 authors...
AbstractThe most recent scientific evidence supports the consumption of cow’s milk and dairy products as part of a balanced diet. However, these days, the public and practicing physicans are exposed to a stream of inconsistent (and often misleading) information regarding the relationship between cow’s milk intake and health in the lay press and in the media. The purpose of this article, in this context, is to facilitate doctor–patient communication on this topic, providing physicians with a seri...
21 CitationsSource
#1Nicolas GoossensH-Index: 22
#2Stefano BellentaniH-Index: 53
Last. David SemelaH-Index: 19
view all 12 authors...
1 Citations
#1Francesco Giuseppe Foschi (AUSL: Academy for Urban School Leadership)H-Index: 26
#2Giorgio BedogniH-Index: 61
Last. G.F. Stefanini (AUSL: Academy for Urban School Leadership)H-Index: 9
view all 17 authors...
Background The estimation of the burden of disease attributable to fatty liver requires studies performed in the general population.
14 CitationsSource
#1Chris EstesH-Index: 20
#2Quentin M. Anstee (Newcastle University)H-Index: 64
Last. Homie RazaviH-Index: 42
view all 31 authors...
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic syndrome continue to grow. The goal of this analysis was to use a Markov model to forecast NAFLD disease burden using currently available data. Methods A model was used to estimate NAFLD and NASH disease progression in eight countries bas...
371 CitationsSource
#1Arrigo F.G. Cicero (UNIBO: University of Bologna)H-Index: 67
#2Alessandro Colletti (UNIBO: University of Bologna)H-Index: 15
Last. Stefano BellentaniH-Index: 53
view all 3 authors...
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with a doubled prevalence in diabetic and obese patients. Almost 1/3 of NAFLD evolves in Non-Alcoholic SteatoHepatitis (NASH), and this can lead to fibrosis and cirrhosis of the liver. However, the main causes of mortality of patients with NAFLD are cardiovascular diseases. At present, there are no specific drugs a...
53 CitationsSource